---
title: LidodermReverse Payment - Joseph Saveri Law Firm
description: The Joseph Saveri Law Firm served as Liaison Counsel in a class action lawsuit the raise the price of Lidoderm. Learn more about how we can help you.
---

case

# Lidoderm Reverse Payment

[SETTLEMENT REACHED](https://www.saverilawfirm.com/settlement/lidoderm-reverse-payment/?hsLang=en)

### ABOUT THE CASE

The Joseph Saveri Law Firm, LLP served as Liaison Counsel for Lidoderm end-payors in a class action lawsuit against Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Inc., and Actavis Inc., along with their respective subsidiaries, in the U.S. District Court for the Northern District of California.

The suit charged Endo, Teikoku, and Actavis with entering into an illegal reverse pay agreement, forcing companies and consumers to pay higher prices for Lidoderm: a patch containing lidocaine, which is typically used to treat post-shingles pain. Endo and Teikoku allegedly provided $96 million worth of branded Lidoderm to Actavis to keep generic lidocaine patches off the market for a year, while promising not to launch its own authorized generic competitor for seven and a half months.

Companies and consumers claimed Endo, Teikoku, and Actavis engaged in an anticompetitive scheme to prevent generic price competition and raise the price of Lidoderm.

“This unlawful agreement had a far-reaching impact on consumers, companies, and other entities who purchase Lidoderm,” said Joseph Saveri, liaison counsel for the end-payor class. “By eliminating generic alternatives, these companies unfairly increased their profits while forcing patients and other payors to accept inflated prices or suffer without medication.”

The suit, *In re Lidoderm Antitrust Litigation*, sought monetary damages for Lidoderm end-payors. In 2017, the Court granted plaintiffs’ motion for class certification. 

---

For further information, read the full case history.   [CLICK HERE +](https://www.saverilawfirm.com/our-cases/lidoderm/#)

###### **FEBRUARY 2017**

The Court concluded the plaintiffs’ claims are appropriate for classwide treatment, and granted their motion to certify a class of Lidoderm end-payors. 

###### **SEPTEMBER 2016**

The firm filed a class action complaint on behalf of Lidoderm end-payors in the United States District Court for the Northern District of California.

###### **NOVEMBER 2014**

The Court largely denied a motion by defendants Endo Pharmaceuticals and Actavis to dismiss the end-payor plaintiffs’ consolidated complaint. 

###### **MAY 2014**

Judge Orrick appointed the firm as Interim Liaison Counsel for the proposed end-payor class. 

###### **APRIL 2014**

The Judicial Panel on Multidistrict Litigation transferred numerous Lidoderm antitrust class actions to the United States District Court for the Northern District of California and assigned the cases to Judge William H. Orrick for coordinated proceedings.

[READ LESS –](https://www.saverilawfirm.com/our-cases/lidoderm/#)

```json
{
  "@context" : "https://schema.org",
  "@type" : "Organization",
  "contactPoint" : [ {
    "@type" : "ContactPoint",
    "areaServed" : "US",
    "availableLanguage" : [ "English" ],
    "contactType" : "Customer Service – San Francisco Office",
    "telephone" : "+1-415-500-6800"
  }, {
    "@type" : "ContactPoint",
    "areaServed" : "US",
    "availableLanguage" : [ "English" ],
    "contactType" : "Customer Service – New York Office",
    "telephone" : "+1-646-527-7310"
  } ],
  "description" : "The Joseph Saveri Law Firm is a leading antitrust and class action litigation firm, representing clients in complex civil cases across the United States.",
  "founder" : {
    "@type" : "Person",
    "name" : "Joseph Saveri"
  },
  "foundingDate" : "2012",
  "location" : [ {
    "@type" : "Place",
    "address" : {
      "@type" : "PostalAddress",
      "addressCountry" : "US",
      "addressLocality" : "San Francisco",
      "addressRegion" : "CA",
      "postalCode" : "94108",
      "streetAddress" : "601 California Street, Suite 1000"
    },
    "geo" : {
      "@type" : "GeoCoordinates",
      "latitude" : 37.792627,
      "longitude" : -122.404744
    }
  }, {
    "@type" : "Place",
    "address" : {
      "@type" : "PostalAddress",
      "addressCountry" : "US",
      "addressLocality" : "New York",
      "addressRegion" : "NY",
      "postalCode" : "10013",
      "streetAddress" : "40 Worth Street, Suite 602"
    },
    "geo" : {
      "@type" : "GeoCoordinates",
      "latitude" : 40.717449,
      "longitude" : -74.006967
    }
  } ],
  "logo" : "https://www.saverilawfirm.com/images/logo.png",
  "name" : "Joseph Saveri Law Firm",
  "sameAs" : [ "https://www.linkedin.com/company/joseph-saveri-law-firm-inc-/", "https://x.com/jsaveri", "https://www.facebook.com/SaveriLawFirm/" ],
  "url" : "https://www.saverilawfirm.com"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "Article",
  "about" : [ {
    "@type" : "Thing",
    "name" : "Antitrust Litigation"
  }, {
    "@type" : "Thing",
    "name" : "Reverse Payment Settlement"
  }, {
    "@type" : "Drug",
    "alternateName" : "Lidoderm",
    "name" : "Lidocaine Patch"
  }, {
    "@type" : "Organization",
    "name" : "United States District Court for the Northern District of California"
  }, {
    "@type" : "Legislation",
    "name" : "Sherman Antitrust Act",
    "url" : "https://www.law.cornell.edu/uscode/text/15"
  } ],
  "author" : {
    "@type" : "Organization",
    "name" : "Joseph Saveri Law Firm LLP",
    "url" : "https://www.saverilawfirm.com"
  },
  "description" : "Class action lawsuit alleging Endo, Teikoku, and Actavis engaged in an illegal reverse payment agreement to delay generic competition for Lidoderm, inflating drug prices. The Court certified the end-payor class in 2017.",
  "headline" : "Lidoderm",
  "mainEntityOfPage" : {
    "@id" : "https://www.saverilawfirm.com/our-cases/lidoderm/",
    "@type" : "WebPage"
  },
  "url" : "https://www.saverilawfirm.com/our-cases/lidoderm/"
}
```